NIH-funded research R01 grant

Hidden HIV in lung immune cells during effective treatment

Official title: Virologic and immunologic impacts of active viral persistence in lung AMs of HIV-1-infected, cART-suppressed individuals

Funded at State University of New York at Buffalo · NIH-11518107 · Data updated 2026-11-12

This work looks at whether HIV stays active inside lung immune cells of people on effective HIV therapy and how that activity might affect immune health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University of New York at Buffalo
NIH-funded
Lab location1 site (Amherst, United States)
Project startMay 17, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$152,468
NIH project number3R01AI176934-03S1
Project IDNIH-11518107 on NIH RePORTER

Who could benefit from this research

Could help

Adults living with HIV who are on suppressive combination antiretroviral therapy (undetectable plasma viral load) and willing to provide lung samples (for example via bronchoscopy/bronchoalveolar lavage) and blood are the ideal candidates.

Less likely to help

People not on ART, children, or anyone unwilling or unable to undergo lung sample procedures are unlikely to benefit or be eligible for participation.

What this research studies

Researchers will collect lung immune cells (alveolar macrophages) and blood from people living with HIV who have undetectable viral loads while on combination antiretroviral therapy. They will use sensitive molecular tests, protein detection, and sequencing to find HIV RNA or proteins inside those lung cells and measure how the cells respond. Laboratory functional studies will test whether persistent viral products drive inflammation or other immune changes, and comparisons with blood cells will show how lung reservoirs differ. The team aims to map the presence and consequences of active virus in lung tissue to inform future treatments.

Why it matters

Potential benefit: If successful, this work could reveal a hidden source of HIV-driven inflammation and help guide therapies to reduce immune activation and lower the chance of virus returning after stopping treatment.

How similar studies have gone: Prior studies have shown active HIV reservoirs in blood T cells but studies focused on lung alveolar macrophages are limited, so this approach is relatively novel while using established lab methods.

Where this research is happening

  • State University of New York at Buffalo
    Amherst, United States
    Active

Researchers

  • Principal investigator: Boliar, Saikat — State University of New York at Buffalo
  • Study coordinator: Boliar, Saikat

Related research

Other NIH-funded projects on the same topics.

  • Improving population health by studying reproductive health and development.

    This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-9795452

  • How noise and hearing loss affect the first step of hearing in the brain

    This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11620270

  • Programmable hydrogels to protect transplanted human OPCs in demyelinating disease

    Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11579956

  • How a mouth bacterium might fuel gum disease and heart risk

    A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11564245

  • New dual-acting treatments against tough Klebsiella pneumoniae infections

    A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11563773

  • Muscle health and aging in postmenopausal women

    This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.

    NIH research State University of New York at Buffalo · Amherst, United States · NIH-11532334

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.